Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on LTR Pharma.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: It’s a small world after all for global microcap index additions LTR Pharma and EZZ Life Science
Health & Biotech
ASX Quarterly Health Wrap: Lift-off for ED nasal spray and record users for pregnancy-monitoring platform
Health & Biotech
LTR Pharma’s ED treatment SPONTAN outperforms with 470% faster absorption
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
ASX stocks leading clinical trials in Australia
Health & Biotech
Bio Curious: Nerve repair house plans to break the IPO drought
Health & Biotech
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
News
ASX August Winners: The 50 best stocks in a volatile month for markets
Stockhead TV
Long Shortz with LTR Pharma: Erectile dysfunction help just a spray away
Health & Biotech
ASX Health Stocks: Lift off for LTR Pharma’s ED therapy under TGA scheme
News
Closing Bell: ASX climbs as Tech takes charge; CBA, AGL gain on earnings, LiveHire doubles
Health & Biotech
LTP enters deal with Aptar Pharma to develop Spontan nasal spray
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Earnings in full swing as CSL tumbles, Temple and Webster skyrockets 27pc
Health & Biotech
ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq
Health & Biotech
ASX Health Stocks: Big tick for Cynata’s stem-cell therapy
Investor Guides
